Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients

International Urology and Nephrology

Volumn 44, Issue 3, 2012, Pages 865-871

  Vaghasiya, Rick P ^a   De Vita, Maria V ^a   Michelis, Michael F ^a  

^a LENOX HILL HOSPITAL   (United States)

Author keywords

Aquaresis; Euvolemic; Hypervolemic; Hyponatremia; Tolvaptan; Vasopressin; Vasopressin receptor antagonist

Indexed keywords

ARGIPRESSIN; CREATININE; GLUCOSE; POTASSIUM; SODIUM; TOLVAPTAN;

AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; GLUCOSE BLOOD LEVEL; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; MEAN ARTERIAL PRESSURE; POTASSIUM BLOOD LEVEL; SERUM OSMOLALITY; SODIUM BLOOD LEVEL; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ARGININE VASOPRESSIN; BENZAZEPINES; BLOOD PRESSURE; DIURETICS; HEART FAILURE; HUMANS; HYPONATREMIA; INAPPROPRIATE ADH SYNDROME; OSMOLAR CONCENTRATION; RECEPTORS, VASOPRESSIN; SODIUM;

EID: 84864276478     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-011-9996-8     Document Type: Article

References (22)

1. Clayton JA, le Jeune IR, Hall IP (2006) Severe hyponatraemia in medical in-patients: aetiology, assessment and outcome. Q J Med 99:505-511 (Pubitemid 44304835)
2. Hoorn EJ, Lindemans J, Zietse R (2006) Development of severe hyponatraemia in hospitalized patients: treatmentrelated risk factors and inadequate management. Nephrol Dial Transplant 21:70-76 (Pubitemid 43057112)
3. Waikar SS, Mount DB, Curhan GC (2009) Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med 122:857-865
4. Wald R, Jaber BL, Price LL et al (2010) Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med 170:294-302
5. Schrier RW (2006) Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med 119(7A):S47-S53
6. Miller M (2006) Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management. JAGS 54:345-353
7. Soupart A, Gross P, Legros J et al (2006) Successful longterm treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist. Clin J Am Soc Nephrol 1:1154-1160
8. Gheorghiade M, Gottlieb SS, Udelson JE et al (2006) Vasopressin V2 receptor blockade with Tolvaptan versus fluid restriction in the treatment of hyponatremia. Am J Cardiol 97:1064-1067
9. Metzger BL, DeVita MV, Michelis MF (2008) Observations regarding the use of the aquaretic agent conivaptan for treatment of hyponatremia. Int Urol Nephrol 40: 725-730
10. Verbalis JG (2006) Whole-body volume regulation and escape from antidiuresis. Am J Med 119(7A):S21-S29 (Pubitemid 44026590)
11. Sieste R, van der Lubbe N, Hoorn EJ (2009) Current and future treatment options in SIADH. Nephrol dial Transplant 3(suppl):iii12-iii19
12. Udelson JE, Smith WB, Hendrix GH et al (2001) Acute hemodynamic effects of conivaptan, a dual V1a and V2 vasopressin receptor antagonist, in patients with advanced heart failure. Circulation 104:2417-2423 (Pubitemid 33108374)
13. Velez JC, Dopson SJ, Sanders DS et al (2010) Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience. Nephrol Dial Transplant 25:1524-1531
14. Schrier RW, Gross P, Gheorghiade M et al (2006) Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355(20):2099-2112 (Pubitemid 44749318)
15. Renneboog B, Musch W, Vandemergel X et al. (2006) Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 119:71. el-71.e8
16. Sajadieh A, Binici Z, Mouridsen MR et al (2009) Mild hyponatremia carries a poor prognosis in community subjects. Am J Med 122:679-686
17. Sandhu HS, Gilles E, DeVita MV et al (2009) Hyponatremia associated with large-bone fracture in elderly patients. Int Urol Nephrol 41:733-737
18. Hoorn EJ, van der Lubbe N, Zietse R (2009) SIADH and hyponatraemia: why does it matter? Nephrol Dial Transplant 3(suppl):iii5-iii11
19. Mohmand HK, Issa D, Ahmad Z et al (2007) Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin J Am Nephrol 2:1110-1117
20. Sterns RH, Hix JK (2009) Overcorrection of hyponatremia is a medical emergency. Kidney Int 76:587-589
21. Gheorghiade M, Konstam MA, Burnett JC Jr et al (2007) Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure. JAMA 297:1332-1343 (Pubitemid 46513234)
22. Otsuka America Pharmaceutical, Inc. (2009) SAMSCA (tolvaptan) tablets product monograph, Otsuka Pharmaceutical Co., Ltd., Tokyo, pp 1-6